JOURNEY STRATEGIC WEALTH LLC Q4 2024 Filing

Filed January 24, 2025

Portfolio Value

$2.7B

Holdings

502

Report Date

Q4 2024

Filing Type

13F-HR

All Holdings (502 positions)

#	Stock	Shares	Value	% Portfolio	Type
501	ORMPORAMED PHARMACEUTICALS INC	12,489	$30K	0.00%
502	ATHAATHIRA PHARMA INC	20,538	$12K	0.00%

PreviousPage 6 of 6